Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market" is generating significant coverage in the Business category, with 3 articles from 3 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Times, WSJ and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 32d ago.
Quick answers
Why is "Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental" trending?
Because 3 independent news sources published 3 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (3)
- Eli Lilly buys psychedelic drugs company AtaiBeckley for $3.8bn The Times · 45d ago
- Eli Lilly to Buy Psychedelic Firm AtaiBeckley for Initial $2.8 Billion WSJ · 45d ago
- Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market Fierce Biotech · 45d ago
Topics
Related trends
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
‘The Matrix’ Director Lilly Wachowski Says Hollywood Won’t Finance Her $10 Million Thriller Because It’s Got a ‘Wall-to-Wall Trans Cast’
5 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as Profit Increases
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.